FGEN Shares Outstanding History
Below is a table of the FGEN shares outstanding history going back to 11/14/2014:

Date FGEN Shares Outstanding
11/14/201455.67M
2/28/201559.14M
4/30/201559.27M
7/31/201560.56M
10/31/201561.34M
1/31/201662.07M
4/30/201662.45M
7/31/201662.79M
10/31/201663.16M
1/31/201763.89M
4/28/201769.94M
7/31/201771.20M
10/31/201782.01M
11/30/201782.20M
1/31/201882.67M
4/30/201883.52M
7/31/201884.33M
10/31/201884.98M
1/31/201985.56M
4/30/201986.22M
7/31/201986.92M
7/29/201965.86M
10/31/201987.25M
1/31/202088.00M
4/30/202089.10M
7/31/202090.36M
10/31/202091.01M
1/31/202191.56M
4/30/202192.13M
7/31/202192.62M

Also see: FGEN Market Cap History
FGEN YTD Return
FGEN Historical Shares Outstanding:
+7.88% CAGR
FGEN Historical Shares Outstanding: +7.88% CAGR

Mouse over chart for data details
11/14/2014 ...7/31/2021
FibroGen is a biopharmaceutical company that developes and commercializes a pipeline of therapeutics. Co. applies its capability in hypoxia-inducible factor (HIF) biology and connective tissue growth factor (CTGF) biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, Co.'s main product, is an inhibitor of HIF-prolyl hydroxylase activity that acts by stimulating the body's natural pathway of erythropoiesis or red blood cell production. Pamrevlumab is Co.'s human monoclonal antibody that inhibits the activity of CTGF for the treatment of idiopathic pulmonary fibrosis, locally advanced unresectable pancreatic cancer, and Duchenne muscular dystroph. We show 30 historical shares outstanding datapoints in our coverage of FGEN's shares outstanding history.

Understanding the changing numbers of FGEN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like FGEN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching FGEN by allowing them to research FGEN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree FGEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
FibroGen (FGEN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

FHTX Shares Outstanding History
FIGS Shares Outstanding History
FIXX Shares Outstanding History
FLDM Shares Outstanding History
FLGT Shares Outstanding History
FLKS Shares Outstanding History
FLXN Shares Outstanding History
FMI Shares Outstanding History
FMTX Shares Outstanding History
FNCH Shares Outstanding History
More Healthcare companies »

 

FGEN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.